Etv2/ER71 induces vascular mesoderm from Flk1+PDGFRα+ primitive mesoderm

Author:

Kataoka Hiroshi12,Hayashi Misato1,Nakagawa Reiko1,Tanaka Yosuke1,Izumi Naoki1,Nishikawa Satomi1,Jakt Martin Lars1,Tarui Hiroshi3,Nishikawa Shin-Ichi1

Affiliation:

1. Laboratory for Stem Cell Biology, RIKEN Center for Developmental Biology, Kobe, Japan;

2. PRESTO, Japan Science and Technology Agency, Saitama, Japan; and

3. Laboratory for Genome Resource and Analysis Unit, RIKEN Center for Developmental Biology, Kobe, Japan

Abstract

AbstractEtv2 (Ets Variant 2) has been shown to be an indispensable gene for the development of hematopoietic cells (HPCs)/endothelial cells (ECs). However, how Etv2 specifies the mesoderm-generating HPCs/ECs remains incompletely understood. In embryonic stem cell (ESC) differentiation culture and Etv2-null embryos, we show that Etv2 is dispensable for generating primitive Flk-1+/PDGFRα+ mesoderm but is required for the progression of Flk-1+/PDGFRα+ cells into vascular/hematopoietic mesoderm. Etv2-null ESCs and embryonic cells were arrested as Flk-1+/PDGFRα+ and failed to generate Flk-1+/PDGFRα− mesoderm. Flk-1+/Etv2+ early embryonic cells showed significantly higher hemato-endothelial potential than the Flk-1+/Etv2− population, suggesting that Etv2 specifies a hemato-endothelial subset of Flk-1+ mesoderm. Critical hemato-endothelial genes were severely down-regulated in Etv2-null Flk-1+ cells. Among those genes Scl, Fli1, and GATA2 were expressed simultaneously with Etv2 in early embryos and seemed to be critical targets. Etv2 reexpression in Etv2-null cells restored the development of CD41+, CD45+, and VE-cadherin+ cells. Expression of Scl or Fli1 alone could also restore HPCs/ECs in the Etv2-null background, indicating that these 2 genes are critical downstream targets. Furthermore, VEGF induced Etv2 potently and rapidly in Flk-1+ mesoderm. We propose that Flk-1+/PDGFRα+ primitive mesoderm is committed into Flk-1+/PDGFRα− vascular mesoderm through Etv2 and that up-regulation of Etv2 by VEGF promotes this commitment.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3